- Browse by Subject
Browsing by Subject "Image Processing"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item AI on the Edge with CondenseNeXt: An Efficient Deep Neural Network for Devices with Constrained Computational Resources(2021-08) Kalgaonkar, Priyank B.; El-Sharkawy, Mohamed A.; King, Brian S.; Rizkalla, Maher E.Research work presented within this thesis propose a neoteric variant of deep convolutional neural network architecture, CondenseNeXt, designed specifically for ARM-based embedded computing platforms with constrained computational resources. CondenseNeXt is an improved version of CondenseNet, the baseline architecture whose roots can be traced back to ResNet. CondeseNeXt replaces group convolutions in CondenseNet with depthwise separable convolutions and introduces group-wise pruning, a model compression technique, to prune (remove) redundant and insignificant elements that either are irrelevant or do not affect performance of the network upon disposition. Cardinality, a new dimension to the existing spatial dimensions, and class-balanced focal loss function, a weighting factor inversely proportional to the number of samples, has been incorporated in order to relieve the harsh effects of pruning, into the design of CondenseNeXt’s algorithm. Furthermore, extensive analyses of this novel CNN architecture was performed on three benchmarking image datasets: CIFAR-10, CIFAR-100 and ImageNet by deploying the trained weight on to an ARM-based embedded computing platform: NXP BlueBox 2.0, for real-time image classification. The outputs are observed in real-time in RTMaps Remote Studio’s console to verify the correctness of classes being predicted. CondenseNeXt achieves state-of-the-art image classification performance on three benchmark datasets including CIFAR-10 (4.79% top-1 error), CIFAR-100 (21.98% top-1 error) and ImageNet (7.91% single model, single crop top-5 error), and up to 59.98% reduction in forward FLOPs compared to CondenseNet. CondenseNeXt can also achieve a final trained model size of 2.9 MB, however at the cost of 2.26% in accuracy loss. Thus, performing image classification on ARM-Based computing platforms without requiring a CUDA enabled GPU support, with outstanding efficiency.Item Automated Methods To Detect And Quantify Histological Features In Liver Biopsy Images To Aid In The Diagnosis Of Non-Alcoholic Fatty Liver Disease(2016-03-31) Morusu, Siripriya; Tuceryan, Mihran; Zheng, Jiang; Tsechpenakis, Gavriil; Fang, ShiaofenThe ultimate goal of this study is to build a decision support system to aid the pathologists in diagnosing Non-Alcoholic Fatty Liver Disease (NAFLD) in both adults and children. The disease is caused by accumulation of excess fat in liver cells. It is prevalent in approximately 30% of the general population in United States, Europe and Asian countries. The growing prevalence of the disease is directly related to the obesity epidemic in developed countries. We built computational methods to detect and quantify the histological features of a liver biopsy which aid in staging and phenotyping NAFLD. Image processing and supervised machine learning techniques are predominantly used to develop a robust and reliable system. The contributions of this study include development of a rich web interface for acquiring annotated data from expert pathologists, identifying and quantifying macrosteatosis in rodent liver biopsies as well as lobular inflammation and portal inflammation in human liver biopsies. Our work on detection of macrosteatosis in mouse liver shows 94.2% precision and 95% sensitivity. The model developed for lobular inflammation detection performs with precision and sensitivity of 79.3% and 81.3% respectively. We also present the first study on portal inflammation identification with 82.1% precision and 88.3% sensitivity. The thesis also presents results obtained for correlation between model computed scores for each of these lesions and expert pathologists' grades.Item Detection of histological features in liver biopsy images to help identify Non-Alcoholic Fatty Liver Disease(2018-04-26) Sethunath, DeepakThis thesis explores a minimally invasive approach of diagnosing Non-Alcoholic Fatty Liver disease (NAFLD) on mice and humans which can be useful for pathologists while performing their diagnosis. NAFLD is a spectrum of diseases going from least severe to most severe – steatosis, steatohepatitis, fibrosis and finally cirrhosis. This disease primarily results from fat deposition in the liver which is unrelated to alcohol or viral causes. In general, it affects individuals having a combination of at least three of the five metabolic syndromes namely, obesity, hypertension, diabetes, hypertriglyceridemia, and hyperlipidemia. Given how common these metabolic syndromes have become, the rate of NAFLD has increased dramatically over the years affecting about three-quarters of all obese individuals including many children, making it one of the most common diseases in United States. Our study focuses on building various computational models which help identify different histological features in a liver biopsy image, thereby analyzing if a person is affected by NAFLD or not. Here, we develop and validate the performance of automated classifiers built using image processing and machine learning methods for detection of macro- and microsteatosis, lobular and portal inflammation and also categorize different types fibrosis in murine and human fatty liver disease and study the correlation of automated quantification of macrosteatosis, lobular and portal inflammation, and fibrosis (amount of collagen) with expert pathologist’s semi-quantitative grades. Our research for macrosteatosis and microsteatosis prediction shows the model’s precision and sensitivity as 94.2%, 95% for macrosteatosis and 79.2%, 77% for microsteatosis. Our models detect lobular and portal inflammation(s) with a precision, sensitivity of 79.6%, 77.1% for lobular inflammation and 86%, 90.4% for portal inflammation. We also present the first study on identification of the six different types of fibrosis having a precision of 85.6% for normal fibrosis and >70% for portal fibrosis, periportal fibrosis, pericellular fibrosis, bridging fibrosis and cirrhosis. We have also quantified the amount of collagen in a liver biopsy and compared it to the pathologist semi-quantitative fibrosis grade.